Drug and Therapy Development for Triple Negative Breast Cancer - Couverture rigide

 
9783527351756: Drug and Therapy Development for Triple Negative Breast Cancer
Couverture rigide
ISBN 10 : 3527351752 ISBN 13 : 9783527351756
Editeur : Blackwell Verlag GmbH, 2023

Synopsis

Drug and Therapy Development for Triple Negative Breast Cancer

The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer

In Drug and Therapy Development for Triple Negative Breast Cancer, a team of distinguished practitioners delivers an in-depth and authoritative discussion of contemporary methods for treating triple negative breast cancer (TNBC). The editors have included material that covers its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies―including nanotherapeutics and photothermal therapies.

As the first comprehensive compilation of modern treatment methods for TNBC, this reference is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis. Readers will also find:

  • A thorough introduction to HER receptors in breast cancers
  • Comprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancer
  • Application of artificial intelligence to breast cancer diagnosis
  • New insights on the role of DNA replication stress and genome instability in breast cancer

Perfect for medicinal and pharmaceutical chemists, Drug and Therapy Development for Triple Negative Breast Cancer will also benefit oncologists and professionals working in the pharmaceutical industry or in hospital settings.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Pravin Kendrekar works as a Scientist Advisor for White Collar Food & Beverages, Pune, India and T&T Pharmaceuticals, Mumbai, India.

Vinayak Adimule works at the Angadi Institute of Technology and Management in Belagavi, India.

Tara Hurst works in the School of Health Sciences at Birmingham City University in Edgbaston, UK.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Éditeur
Blackwell Verlag GmbH
Date d'édition
2023
Langue
anglais
ISBN 10 
3527351752
ISBN 13 
9783527351756
Reliure
Relié
Numéro d'édition
1
Nombre de pages
320
Éditeur
Kendrekar Pravin, Adimule Vinayak, Hurst Tara
Coordonnées du fabricant
non disponible
Personne responsable
non disponible